Comparison of results of treatment of neuroendocrine tumors NET G3 using different treatment modalities
Abstract
The WHO classification of neuroendocrine tumors from 2017 and 2019 introduces a new category of neuroendocrine tumors (NET), namely a well-differentiated high-grade neuroendocrine tumor (NET G3), which is different from poorly differentiated neuroendocrine carcinomas (NEC).